This encourages me: “The pharmaceutical industry is poised [for] a revolution which will oust the blockbuster drug, and usher in targeted treatments based on a fresh understanding of human biology. … the pharmaceutical firms currently most profitable ‘may well be’ those slowest to change, setting the scene for a major shake-up of company rankings. … The new generation of drugs will be based largely around larger molecules, such as proteins, whose composition is becoming the focus of increasing research. Such molecules, although complex, will be faster to develop thanks to the help of biochemistry software. … The treatments' speed of development will also make them cheaper to produce, putting them within the budget of developing countries which often have more severe health concerns, yet little cash to pay for treatments.”